Medical Oncology

, 32:95 | Cite as

Wnt signaling regulates the stemness of lung cancer stem cells and its inhibitors exert anticancer effect on lung cancer SPC-A1 cells

  • Xueyan Zhang
  • Yuqing Lou
  • Huimin Wang
  • Xiaoxuan Zheng
  • Qianggang Dong
  • Jiayuan Sun
  • Baohui HanEmail author
Original Paper


Wnt signaling plays an important role in regulating the activity of cancer stem cells (CSCs) in a variety of cancers. In this study, we explored the role of Wnt signaling in the lung cancer stem cells (LCSCs). LCSCs were obtained by sphere culture, for which human lung adenocarcinoma cell line SPC-A1 was treated with IGF, EGF and FGF-10. The stemness of LCSCs was confirmed by immunofluorescence, and pathway analysis was performed by functional genome screening and RT-PCR. The relationship between the identified signaling pathway and the expression of the stemness genes was explored by agonist/antagonist assay. Moreover, the effects of different signaling molecule inhibitors on sphere formation, cell viability and colony formation were also analyzed. The results showed that LCSCs were successfully generated as they expressed pluripotent stem cell markers Nanog and Oct 4, and lung distal epithelial markers CCSP and SP-C, by which the phenotype characterization of stem cells can be confirmed. The involvement of Wnt pathway in LCSCs was identified by functional genome screening and verified by RT-PCR. The expression of Wnt signaling components was closely related to the expression of the Nanog and Oct 4. Furthermore, targeting Wnt signaling pathway by using different signaling molecule inhibitors can exert anticancer effects. In conclusion, Wnt signaling pathway is involved in the stemness regulation of LCSCs and might be considered as a potential therapeutic target in lung adenocarcinoma.


Functional genome screening Lung cancer stem cells Pluripotent stem cell markers Sphere culture Wnt signaling pathway 



This work was funded by Shanghai Natural Science Foundation (No. 13ZR1438600).

Conflict of interest



  1. 1.
    Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11–30.CrossRefPubMedGoogle Scholar
  2. 2.
    Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN, et al. Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010;116:544–73.CrossRefPubMedCentralPubMedGoogle Scholar
  3. 3.
    Pacheco-Pinedo EC, Durham AC, Stewart KM, Goss AM, Lu MM, Demayo FJ, et al. Wnt/beta-catenin signaling accelerates mouse lung tumorigenesis by imposing an embryonic distal progenitor phenotype on lung epithelium. J Clin Invest. 2011;121:1935–45.CrossRefPubMedCentralPubMedGoogle Scholar
  4. 4.
    Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, et al. Cancer stem cells—perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res. 2006;66:9339–44.CrossRefPubMedGoogle Scholar
  5. 5.
    Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di Virgilio A, et al. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ. 2008;15:504–14.CrossRefPubMedGoogle Scholar
  6. 6.
    Wu K, House L, Liu W, Cho WC. Personalized targeted therapy for lung cancer. Int J Mol Sci. 2012;13:11471–96.CrossRefPubMedCentralPubMedGoogle Scholar
  7. 7.
    Takebe N, Ivy SP. Controversies in cancer stem cells: targeting embryonic signaling pathways. Clin Cancer Res. 2010;16:3106–12.CrossRefPubMedGoogle Scholar
  8. 8.
    Park KS, Martelotto LG, Peifer M, Sos ML, Karnezis AN, Mahjoub MR, et al. A crucial requirement for Hedgehog signaling in small cell lung cancer. Nat Med. 2011;17:1504–8.CrossRefPubMedCentralPubMedGoogle Scholar
  9. 9.
    Sullivan JP, Spinola M, Dodge M, Raso MG, Behrens C, Gao B, et al. Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling. Cancer Res. 2010;70:9937–48.CrossRefPubMedCentralPubMedGoogle Scholar
  10. 10.
    Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277–300.CrossRefPubMedGoogle Scholar
  11. 11.
    Spillane JB, Henderson MA. Cancer stem cells: a review. ANZ J Surg. 2007;77:464–8.CrossRefPubMedGoogle Scholar
  12. 12.
    Ishii H, Iwatsuki M, Ieta K, Ohta D, Haraguchi N, Mimori K, et al. Cancer stem cells and chemoradiation resistance. Cancer Sci. 2008;99:1871–7.CrossRefPubMedGoogle Scholar
  13. 13.
    Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature. 1994;367:645–8.CrossRefPubMedGoogle Scholar
  14. 14.
    Colak S, Medema JP. Cancer stem cells—important players in tumor therapy resistance. FEBS J. 2014;281:4779–91.CrossRefPubMedGoogle Scholar
  15. 15.
    Deleyrolle LP, Ericksson G, Morrison BJ, Lopez JA, Burrage K, Burrage P, et al. Determination of somatic and cancer stem cell self-renewing symmetric division rate using sphere assays. PLoS One. 2011;6:e15844.CrossRefPubMedCentralPubMedGoogle Scholar
  16. 16.
    Bertolini G, Roz L, Perego P, Tortoreto M, Fontanella E, Gatti L, et al. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci USA. 2009;106:16281–6.CrossRefPubMedCentralPubMedGoogle Scholar
  17. 17.
    Chen YC, Hsu HS, Chen YW, Tsai TH, How CK, Wang CY, et al. Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells. PLoS One. 2008;3:e2637.CrossRefPubMedCentralPubMedGoogle Scholar
  18. 18.
    Leung EL, Fiscus RR, Tung JW, Tin VP, Cheng LC, Sihoe AD, et al. Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties. PLoS One. 2010;5:e14062.CrossRefPubMedCentralPubMedGoogle Scholar
  19. 19.
    Levina V, Marrangoni AM, DeMarco R, Gorelik E, Lokshin AE. Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties. PLoS One. 2008;3:e3077.CrossRefPubMedCentralPubMedGoogle Scholar
  20. 20.
    Winkler ME, Mauritz C, Groos S, Kispert A, Menke S, Hoffmann A, et al. Serum-free differentiation of murine embryonic stem cells into alveolar type II epithelial cells. Cloning Stem Cells. 2008;10:49–64.CrossRefPubMedGoogle Scholar
  21. 21.
    Zhou CH, Yang SF, Li PQ. Human lung cancer cell line SPC-A1 contains cells with characteristics of cancer stem cells. Neoplasma. 2012;59:685–92.CrossRefPubMedGoogle Scholar
  22. 22.
    Singh I, Mehta A, Contreras A, Boettger T, Carraro G, Wheeler M, et al. Hmga2 is required for canonical WNT signaling during lung development. BMC Biol. 2014;12:21.CrossRefPubMedCentralPubMedGoogle Scholar
  23. 23.
    Uematsu K, He B, You L, Xu Z, McCormick F, Jablons DM. Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression. Oncogene. 2003;22:7218–21.CrossRefPubMedGoogle Scholar
  24. 24.
    You L, He B, Xu Z, Uematsu K, Mazieres J, Mikami I, et al. Inhibition of Wnt-2-mediated signaling induces programmed cell death in non-small-cell lung cancer cells. Oncogene. 2004;23:6170–4.CrossRefPubMedGoogle Scholar
  25. 25.
    Malanchi I, Peinado H, Kassen D, Hussenet T, Metzger D, Chambon P, et al. Cutaneous cancer stem cell maintenance is dependent on beta-catenin signalling. Nature. 2008;452:650–3.CrossRefPubMedGoogle Scholar
  26. 26.
    Chien AJ, Moore EC, Lonsdorf AS, Kulikauskas RM, Rothberg BG, Berger AJ, et al. Activated Wnt/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model. Proc Natl Acad Sci USA. 2009;106:1193–8.CrossRefPubMedCentralPubMedGoogle Scholar
  27. 27.
    Kawaguchi-Ihara N, Murohashi I, Nara N, Tohda S. Promotion of the self-renewal capacity of human acute leukemia cells by Wnt3A. Anticancer Res. 2008;28:2701–4.PubMedGoogle Scholar
  28. 28.
    Yang W, Yan HX, Chen L, Liu Q, He YQ, Yu LX, et al. Wnt/beta-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cells. Cancer Res. 2008;68:4287–95.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • Xueyan Zhang
    • 1
  • Yuqing Lou
    • 1
  • Huimin Wang
    • 1
  • Xiaoxuan Zheng
    • 1
  • Qianggang Dong
    • 2
  • Jiayuan Sun
    • 1
  • Baohui Han
    • 1
    Email author
  1. 1.Department of Pulmonary Medicine, Shanghai Chest HospitalShanghai Jiao Tong UniversityShanghaiChina
  2. 2.Section of Cancer Stem Cells, Shanghai Cancer InstituteShanghai Jiao Tong UniversityShanghaiChina

Personalised recommendations